ImplemeNtation oF demOnstration pRoject for Health systeMs: Atrial Fibrillation (INFORM-AF) Part 1

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02569528

Acronym

INFORM-AF

Enrollment

Registered

2015-10-06

Start date

2015-10-31

Completion date

2017-03-02

Last updated

2017-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

atrial fibrillation, anticoagulation

Brief summary

The goal of this study is to learn about the patient and provider perceptions, priorities, preferences, and willingness to use/prescribe anticoagulation as a stroke prevention therapy in patients with atrial fibrillation. Qualitative interviews will be performed with atrial fibrillation patients and providers caring for atrial fibrillation patients. The investigators want to understand the factors that influence decision-making about anticoagulation medications, and to gain insight into patients' and providers' knowledge of the risk of stroke and bleeding associated with oral anticoagulation. This feedback will help provide better education to providers caring for patients with atrial fibrillation and better care to patients with atrial fibrillation by developing tools to optimize the appropriate use of oral anticoagulation for patients with atrial fibrillation.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Patient Inclusion Criteria: 1. adult patient age 18 or older; 2. English speaking; 3. diagnosed atrial fibrillation; 4. at least 1 risk factor for congestive heart failure, hypertension, age, diabetes, stroke (CHADS2) or 2 risk factors for CHADS2 with vascular disease, age, and sex (CHADS2-VASc) ; 5. no documented cognitive impairment per the medical record; 6. not being prescribed an oral anticoagulant Provider Inclusion Criteria: 1\. physician at one of the study sites treating patients diagnosed with atrial fibrillation

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame	Description
Perceptions of using anticoagulation as a stroke prevention therapy in atrial fibrillation, as measured by survey and interview	one hour	Each telephone interview (data collection time point) will be approximately one hour

Secondary

Measure	Time frame	Description
Willingness to use anticoagulation as a stroke prevention therapy in atrial fibrillation, as measured by survey and interview	one hour	Each telephone interview (data collection time point) will be approximately one hour
preferences for using anticoagulation as a stroke prevention therapy in atrial fibrillation, as measured by survey and interview	one hour	Each telephone interview (data collection time point) will be approximately one hour
priorities for using anticoagulation as a stroke prevention therapy in atrial fibrillation, as measured by survey and interview	one hour	Each telephone interview (data collection time point) will be approximately one hour

Countries

United States

Outcome results